I do not know whats up with you obsession why someone buys or sells a stock at a certain price but at the time I still belived they could pull off the HIV indication and that they could generate some cashflow and maybe a substantial partnership in the HIV sector. I did not relaize that managment was that clueless and AMAREX that corrupt. All other indications would not and have not pushed us anywhere near the finish line (drug approval) in the near-term.

Cyrus has almost cleared the house and put an end to all the funny stuff. I was a little bit sceptical at first but it seems he is managing the company in a professional manner and cytodyn has a small but real chance of success.